Higher Crohn's disease rates with vedolizumab: a study

Published Date: 13 Mar 2023

The study results may prompt doctors to choose vedolizumab over anti-TNF therapy as the first-line treatment for Crohn's disease.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Exercise can counter detrimental effects of cancer treatment, review suggests

2.

Treatment of Smoldering Myeloma Cuts Progression Rate in Half

3.

In Resectable Lung Cancer, Perioperative Nivolumab Increases EFS.

4.

Is global cancer care losing its human touch?

5.

When in Breast Cancer Treatment Are CDK4/6 Inhibitors Best?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot